Hematopoiesis-related microRNA expression in myelodysplastic syndromes

References

• Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999;340:1649–1660.
   PubMed Web of Science ®Google Scholar
• Germing U, Strupp C, Kundgen A, et al No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 2004;89:905–910.
   PubMed Web of Science ®Google Scholar
• Bennett JM, Catovsky D, Daniel MT, et al Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189–199.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100:2292–2302.
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau MM, et al International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079–2088.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Malcovati L. Myelodysplastic syndromes – coping with ineffective hematopoiesis. N Engl J Med 2005;352:536–538.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001;294:853–858.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259–269.
   PubMed Web of Science ®Google Scholar
• Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006;25:6188–6196.
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD, et al Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999–3004.
   PubMed Web of Science ®Google Scholar
• Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004;303:83–86.
   PubMed Web of Science ®Google Scholar
• Monticelli S, Ansel KM, Xiao C, et al MicroRNA profiling of the murine hematopoietic system. Genome Biol 2005;6:R71.
   PubMed Web of Science ®Google Scholar
• Ramkissoon SH, Mainwaring LA, Ogasawara Y, et al Hematopoietic-specific microRNA expression in human cells. Leuk Res 2006;30:643–647.
   PubMed Web of Science ®Google Scholar
• Felli N, Fontana L, Pelosi E, et al MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005. 102:18081–18086.
   PubMed Web of Science ®Google Scholar
• Fazi F, Rosa A, Fatica A, et al A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005;123:819–831.
   PubMed Web of Science ®Google Scholar
• Garzon R, Pichiorri F, Palumbo T, et al MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 2006;103:5078–5083.
   PubMed Web of Science ®Google Scholar
• Georgantas RW III, Hildreth R, Morisot S, et al CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 2007;104:2750–2755.
   PubMed Web of Science ®Google Scholar
• Navarro A, Gaya A, Martinez A, et al MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 2008;111:2825–2832.
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Mufti GJ. Apoptosis and its significance in MDS: controversies revisited. Leuk Res 1999;23:777–785.
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT, et al A microRNA polycistron as a potential human oncogene. Nature 2005;435:828–833.
   PubMed Web of Science ®Google Scholar
• Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 2007;282:2130–2134.
   PubMed Web of Science ®Google Scholar
• Taguchi A, Yanagisawa K, Tanaka M, et al Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res 2008;68:5540–5545.
   PubMed Web of Science ®Google Scholar
• Lu Z, Liu M, Stribinskis V, et al MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008;27:4373–4379.
   PubMed Web of Science ®Google Scholar
• Connolly E, Melegari M, Landgraf P, et al Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 2008;173:856–864.
   PubMed Web of Science ®Google Scholar
• Flores-Figueroa E, Gutierrez-Espindola G, Montesinos JJ, rana-Trejo RM, Mayani H. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Leuk Res 2002;26:677–686.
   PubMed Web of Science ®Google Scholar
• Micheva I, Thanopoulou E, Michalopoulou S, et al Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dendritic cells in patients with myelodysplastic syndromes. Clin Immunol 2004;113:310–317.
   PubMed Web of Science ®Google Scholar
• Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006;103:12481–12486.
   PubMed Web of Science ®Google Scholar
• Debernardi S, Skoulakis S, Molloy G, Chaplin T, xon-McIver A, Young BD. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007;21:912–916.
   PubMed Web of Science ®Google Scholar
• Marcucci G, Radmacher MD, Maharry K, et al MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008;358:1919–1928.
   PubMed Web of Science ®Google Scholar
• Pfeilstocker M, Karlic H, Nosslinger T, et al Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications. Leuk Lymphoma 2007;48:1900–1909.
   PubMed Web of Science ®Google Scholar